Impact Submissions by University

UoA 2 - pre-clinical studies

The submitted impact overview statements and impact case studies* are shown in the columns respectively.

Impact overview statement

Novel antiviral strategies

Impact overview statement

Preventing nausea and vomiting to enable a more effective treatment of cancer Development of biomarker of pyrrolizidine alkaloid-induced liver injury: impact on public health with diagnosis and prevention of pyrrolizidine alkaloid poisonings Serendipity consequence of debunking the existence of STAP stem cells

Impact overview statement

Epidemiological investigation, antiviral and vaccine for influenza virus infection Commercialization of biomarkers for prediction and therapeutic intervention of cardiometabolic diseases: from bench to bedsides and beyond

* Save for those exempted from publication pursuant to the approval granted by the University Grants Committee.